Lilly’s long-acting insulin wins NICE blessing ahead of potential UK approval

For patients living with Type 2 diabetes in the United Kingdom, a more convenient treatment option may be on the horizon after the country's drug price watchdog recommended Eli Lilly’s once-weekly | Hundreds of thousands of patients with type 2 diabetes could eventually make the switch to a weekly insulin injection and reduce their annual injections by 85% after NICE, the U.K.’s drug cost watchdog, gave Lilly's Onswik its seal of approval for NHS coverage.

Raccontata daindependent.co.ukfiercepharma.com